Simulations Plus Other Non-Current Liabilities 2012-2026 | SLP
Simulations Plus other non-current liabilities from 2012 to 2026. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
|
Simulations Plus Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2025 | |
| 2024 | |
| 2023 | $3 |
| 2022 | |
| 2021 | |
| 2020 | $4 |
| 2019 | |
| 2018 | $3 |
| 2017 | $6 |
| 2016 | |
| 2015 | $1 |
| 2014 | $2 |
| 2013 | $0 |
| 2012 | |
| 2011 | |
|
Simulations Plus Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-11-30 | |
| 2025-08-31 | |
| 2025-05-31 | |
| 2025-02-28 | |
| 2024-11-30 | |
| 2024-08-31 | |
| 2024-05-31 | |
| 2024-02-29 | $2 |
| 2023-11-30 | $4 |
| 2023-08-31 | $3 |
| 2023-05-31 | |
| 2023-02-28 | |
| 2022-11-30 | |
| 2022-08-31 | |
| 2022-05-31 | |
| 2022-02-28 | |
| 2021-11-30 | |
| 2021-08-31 | |
| 2021-05-31 | $3 |
| 2021-02-28 | $4 |
| 2020-11-30 | $4 |
| 2020-08-31 | $4 |
| 2020-05-31 | $4 |
| 2020-02-29 | |
| 2019-11-30 | |
| 2019-08-31 | |
| 2019-05-31 | $2 |
| 2019-02-28 | $2 |
| 2018-11-30 | $2 |
| 2018-08-31 | $3 |
| 2018-05-31 | $3 |
| 2018-02-28 | $3 |
| 2017-11-30 | $3 |
| 2017-08-31 | $6 |
| 2017-05-31 | |
| 2017-02-28 | |
| 2016-11-30 | |
| 2016-08-31 | |
| 2016-05-31 | |
| 2016-02-29 | $1 |
| 2015-11-30 | $1 |
| 2015-08-31 | $1 |
| 2015-05-31 | $3 |
| 2015-02-28 | $4 |
| 2014-11-30 | $4 |
| 2014-08-31 | $2 |
| 2014-05-31 | $2 |
| 2014-02-28 | $0 |
| 2013-11-30 | $0 |
| 2013-08-31 | $0 |
| 2013-05-31 | |
| 2013-02-28 | |
| 2012-11-30 | |
| 2012-08-31 | |
| 2012-05-31 | |
| 2012-02-29 | |
| 2011-11-30 | |
| 2011-08-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Computer Software | $0.263B | $0.079B |
| Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microsoft (MSFT) | United States | $2753.943B | 24.11 |
| Oracle (ORCL) | United States | $397.153B | 23.29 |
| SAP SE (SAP) | Germany | $200.369B | 23.43 |
| Intuit (INTU) | United States | $97.052B | 20.83 |
| Adobe (ADBE) | United States | $91.086B | 12.68 |
| Synopsys (SNPS) | United States | $75.138B | 41.38 |
| Cadence Design Systems (CDNS) | United States | $73.347B | 48.30 |
| Dassault Systemes SA (DASTY) | France | $26.551B | 15.11 |
| SS&C Technologies Holdings (SSNC) | United States | $16.192B | 12.48 |
| PTC (PTC) | United States | $15.879B | 17.91 |
| Manhattan Associates (MANH) | United States | $7.161B | 34.05 |
| Pegasystems (PEGA) | United States | $6.655B | 28.74 |
| Descartes Systems Group (DSGX) | Canada | $5.426B | 33.91 |
| Open Text (OTEX) | Canada | $5.117B | 5.65 |
| Trend Micro (TMICY) | Japan | $4.192B | 18.33 |
| ACI Worldwide (ACIW) | United States | $4.058B | 17.19 |
| CommVault Systems (CVLT) | United States | $3.908B | 37.98 |
| Sapiens (SPNS) | Israel | $2.433B | 31.04 |
| Blackbaud (BLKB) | United States | $1.574B | 12.02 |
| PROS Holdings (PRO) | United States | $1.123B | 0.00 |
| Progress Software (PRGS) | United States | $1.121B | 5.56 |
| Rand Worldwide (RWWI) | United States | $0.506B | 0.00 |
| OptimizeRx (OPRX) | United States | $0.115B | 9.15 |
| NetSol Technologies (NTWK) | United States | $0.040B | 21.06 |
| Neonode (NEON) | Sweden | $0.024B | 0.00 |
| Smith Micro Software (SMSI) | United States | $0.018B | 0.00 |
| Wetouch Technology (WETH) | China | $0.016B | 2.21 |
| Global Interactive Technologies (GITS) | South Korea | $0.009B | 0.00 |
| Magic Software Enterprises (MGIC) | Israel | $0.000B | 18.90 |